How did MSD decide which specific kidney biomarkers to target?

MSD worked with the Critical Path Institute (C-Path) and the Predictive Safety Testing Consortium (PSTC) to ensure that we were offering the most useful and specific toxicology biomarker immunoassays.

Was this answer helpful?

Related FAQs

Browse Our Products

By Analytes
By Applications
Search
Customer Service/Orders


Scientific/Technical Support


Instrument Support


Company Headquarters